<DOC>
	<DOCNO>NCT00399724</DOCNO>
	<brief_summary>Primary objective : - To determine optimal treatment algorithm clinical use insulin glargine base incidence severe hypoglycaemia . Secondary objective : - To determine treatment algorithm incidence asymptomatic , symptomatic nocturnal hypoglycaemia . - To determine difference glycaemic control measure HbA1c fast blood glucose treatment algorithm . - To determine difference glycaemic control measure HbA1c fast blood glucose baseline end treatment . - To obtain safety data use insulin glargine treatment algorithm . - To measure change subject weight insulin dose baseline end treatment . - To determine subject quality life treatment satisfaction ( sub-study )</brief_summary>
	<brief_title>A Trial Comparing Lantus Algorithms Achieve Normal Blood Glucose Targets Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Inclusion criterion : Subjects Type 2 Diabetes Mellitus , Subjects antidiabetic treatment ( oral and/or insulin therapy ) &gt; 6 month , Subjects require basal longacting insulin control hyperglycaemia , HbA1c value &gt; 7.0 % &lt; 12 % , BMI &lt; 40 kg/mÂ² . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>